Almost a $1 a share.... more than enough to fund development of this drug for next 12-18 months. A great position to be in.
The last time we had a big jump like this, February 2011, the run continued for about a week
and they have a partnership with ELAN on another drug - collected $11 milestone payment last quarter.
I hope that the amount of cash they have, it causes a floor in the share price in the 2.50 area
that long time what if something go wrong. and they will need to rise cash.